CLASS II ONGOING Device recall · Reported 5 Oct 2022 · FDA Enforcement Report

Ambra PACS, Ambra ProViewer recalled by DICOM Grid

Dicom Grid is recalling Ambra PACS, Ambra ProViewer, distributed in 43 states. The recall was initiated on 23 Jun 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: AMBRHEALTHSOLUTIONS0; Software Version: 3.22.2.0 and 3.22.3.0.
Quantity recalled671 downloads

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1818-2022
FDA event ID
90817
Recalling firm
Dicom Grid, New York, NY
Classification
Class II
Status
Ongoing
Recall initiated
23 Jun 2022
FDA classified
27 Sep 2022
Reported
5 Oct 2022
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

23 Jun 2022Recall initiated by company
27 Sep 2022Classified by FDA+96 days
5 Oct 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A race condition between the storage system and services database has the potential to revert edits made to patient information upon first ingestion of a study.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Ambra PACS, Ambra ProViewer. Software for use as a primary diagnostic and analysis tool for diagnostic images.

Where it was distributed

Domestic: AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, MD, MA, MI, MN, MS, MO, NE, NV, NH, NJ, NM, NY, NC, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, DC, & PR.

ArkansasCaliforniaColoradoConnecticutDistrict of ColumbiaDelawareFloridaGeorgiaHawaiiIowaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMichiganMinnesota

Questions about this recall

Why was it recalled?

A race condition between the storage system and services database has the potential to revert edits made to patient information upon first ingestion of a study.

Which lots are affected?

UDI-DI: AMBRHEALTHSOLUTIONS0; Software Version: 3.22.2.0 and 3.22.3.0.

Where was it sold?

Domestic: AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, MD, MA, MI, MN, MS, MO, NE, NV, NH, NJ, NM, NY, NC, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, DC, & PR.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Dicom Grid

All 3
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIIntelerad InteleShare recalled by DICOM GridDicom GridLabeling Errors44 states
DeviceCLASS IIAmbra PACS recalled by Dicom GridDicom GridDevice Malfunction27 states

Other Test Kits & Diagnostics recalls

All 2,663